Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$46,708.50
Apr 1, 2024
For-profit organization
Novel Biotechnology Inc.-2024-2025-1017799
1017799
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
$91,000.00
Mar 1, 2024
For-profit organization
Refining NBx for industrial performance
1015922
Novel NBx Platform significantly improves productivity in plasmid DNA manufacturing, securing patents for engineered bacteria. Beyond enhancing productivity, this organism produces higher-quality material with fewer host-related impurities, benefiting various bio-based products, especially protein-based ones like growth factors.
The Human Growth Factor market, relying on E.coli, faces challenges of low yields and batch failures. Novel's bacteria demonstrates lower endotoxin production and up to 20X productivity in plasmid DNA manufacturing compared to E.coli. Building on this success, Novel aims to create a disruptive manufacturing platform for EGF and FGF growth factors, anticipating these advantages will transfer to other bioproducts.
$30,000.00
Nov 15, 2023
For-profit organization
Lab tech youth
1012490
Novel has developed a novel platform for producing plasmids (NBX). Cloning is the process used to create a bacterial vector containing a gene of interest. There are several industry-standard procedures available for cloning, including restriction digestion-ligation-based cloning, Gibson assembly, and Golden Gate assembly. Once complete, the cloned plasmid is introduced into a bacterial cell (NBX) using a procedure called transformation. It is important to determine an optimized recipe for the transformation mixture based on the cloning mixture and heat shock parameters based on the format of the reaction tube. The trainee will work on these aspects, gaining experience in cloning/assembly methods transformation methods and recovery methods.
$30,000.00
Oct 1, 2023
For-profit organization
Media development youth
1010924
Composition of the media plays significantly important role in the quality and quantity of the industrially important materials produced by bacteria. The project will focus on the production of a chemically defined and animal component free media for the production plasmids, proteins, and metabolites.